Physician profile
Braxton Turner
NPI 1841271467
$3,181.88
in general payments reported to CMS, 2019-2025
36 companies · $575 in 2025
The $575 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $362 · 2021: $596 · 2022: $587 · 2023: $193 · 2024: $280 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $884.31 | 2019-2025 | Relistor |
| Medtronic, INC. | $556.49 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Synchromedii |
| Forte Bio-Pharma LLC | $273.39 | 2019-2025 | Prolate, Nalocet, Tanlor |
| Boston Scientific Corporation | $137.95 | 2021-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $118.16 | 2020-2025 | Eterna |
| Collegium Pharmaceutical, INC. | $101.87 | 2019-2022 | |
| Nevro Corp. | $96.65 | 2019-2024 | Senza |
| Sentynl Therapeutics, INC. | $91.69 | 2019 | |
| Daiichi Sankyo INC. | $89.86 | 2019 | |
| Grt US Holding, INC. | $77.12 | 2021-2022 | |
| Medtronic USA, INC. | $73.92 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.62 | 2019 | |
| Spr Therapeutics, INC | $53.15 | 2023-2024 | Sprint Pns System |
| Biotronik Nro, INC. | $47.55 | 2025 | Prospera |
| Biodelivery Sciences International, INC. | $38.81 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $38.66 | 2019-2021 | |
| Valinor Pharma, LLC | $37.31 | 2025 | Movantik |
| Virtus Pharmaceuticals LLC | $36.66 | 2021-2024 | Levorphanol Tartrate |
| Averitas Pharma INC. | $31.57 | 2024-2025 | Qutenza |
| Idorsia Pharmaceuticals US INC | $31.04 | 2022-2023 | Quviviq |
| Vertex Pharmaceuticals Incorporated | $31.02 | 2025 | |
| Protega Pharmaceutials INC | $30.64 | 2022-2024 | Roxybond |
| Bioventus LLC | $26.28 | 2022 | |
| Saluda Medical Americas, INC. | $26.07 | 2024 | Evoke |
| Arbor Pharmaceuticals, INC. | $25.52 | 2021 | |
| Masimo Corporation | $18.33 | 2023 | Patient Safetynet System |
| Spinal Simplicity, LLC | $18.06 | 2023 | Ha Minuteman G3-R |
| Assertio Therapeutics, INC. | $17.25 | 2019 | |
| Shionogi INC | $16.51 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.78 | 2025 | Iovera, Zilretta |
| Pfizer INC. | $15.77 | 2019 | |
| Merit Medical Systems INC | $15.45 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $14.00 | 2019 | |
| Baudax Bio INC. | $11.79 | 2021 | |
| Radius Health, INC. | $11.41 | 2021 | |
| Mml US, INC. | $11.22 | 2025 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Braxton Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.